Annual Operating Expenses
$159.79 M
-$843.00 K-0.52%
31 December 2023
Summary:
C4 Therapeutics annual total operating expenses is currently $159.79 million, with the most recent change of -$843.00 thousand (-0.52%) on 31 December 2023. During the last 3 years, it has risen by +$66.14 million (+70.63%). CCCC annual operating expenses is now -0.52% below its all-time high of $160.63 million, reached on 31 December 2022.CCCC Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$43.61 M
+$10.16 M+30.37%
30 September 2024
Summary:
C4 Therapeutics quarterly total operating expenses is currently $43.61 million, with the most recent change of +$10.16 million (+30.37%) on 30 September 2024. Over the past year, it has increased by +$4.73 million (+12.16%). CCCC quarterly operating expenses is now at all-time high.CCCC Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CCCC Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.5% | +12.2% |
| 3 y3 years | +70.6% | +33.1% |
| 5 y5 years | +346.9% | +183.8% |
CCCC Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -0.5% | +70.6% | at high | +33.1% |
| 5 y | 5 years | -0.5% | +346.9% | at high | +183.8% |
| alltime | all time | -0.5% | +346.9% | at high | +183.8% |
C4 Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $43.61 M(+30.4%) |
| June 2024 | - | $33.45 M(+1.9%) |
| Mar 2024 | - | $32.82 M(-19.3%) |
| Dec 2023 | $159.79 M(-0.5%) | $40.69 M(+4.7%) |
| Sept 2023 | - | $38.88 M(-3.4%) |
| June 2023 | - | $40.23 M(+0.6%) |
| Mar 2023 | - | $39.99 M(-2.8%) |
| Dec 2022 | $160.63 M(+25.6%) | $41.15 M(+4.9%) |
| Sept 2022 | - | $39.24 M(-4.8%) |
| June 2022 | - | $41.22 M(+5.6%) |
| Mar 2022 | - | $39.02 M(+10.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $127.92 M(+36.6%) | $35.33 M(+7.9%) |
| Sept 2021 | - | $32.75 M(+2.7%) |
| June 2021 | - | $31.90 M(+14.2%) |
| Mar 2021 | - | $27.93 M(+2.8%) |
| Dec 2020 | $93.64 M(+64.8%) | $27.16 M(+1.4%) |
| Sept 2020 | - | $26.80 M(+30.5%) |
| June 2020 | - | $20.53 M(+7.2%) |
| Mar 2020 | - | $19.15 M(+2.4%) |
| Dec 2019 | $56.83 M(+59.0%) | $18.71 M(+21.8%) |
| Sept 2019 | - | $15.37 M |
| Dec 2018 | $35.75 M | - |
FAQ
- What is C4 Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for C4 Therapeutics?
- What is C4 Therapeutics annual operating expenses year-on-year change?
- What is C4 Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for C4 Therapeutics?
- What is C4 Therapeutics quarterly operating expenses year-on-year change?
What is C4 Therapeutics annual total operating expenses?
The current annual operating expenses of CCCC is $159.79 M
What is the all time high annual operating expenses for C4 Therapeutics?
C4 Therapeutics all-time high annual total operating expenses is $160.63 M
What is C4 Therapeutics annual operating expenses year-on-year change?
Over the past year, CCCC annual total operating expenses has changed by -$843.00 K (-0.52%)
What is C4 Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of CCCC is $43.61 M
What is the all time high quarterly operating expenses for C4 Therapeutics?
C4 Therapeutics all-time high quarterly total operating expenses is $43.61 M
What is C4 Therapeutics quarterly operating expenses year-on-year change?
Over the past year, CCCC quarterly total operating expenses has changed by +$4.73 M (+12.16%)